The aim of the current study was to determine whether an altered pulmonary blood flow per se is associated with phenotypic changes in the lung vasculature akin to PH. For the study, human lung tissue from the contralateral lung was obtained at least 2 years after pneumonectomy, bilobectomy or lobectomy of the left upper lobe. Healthy control tissue was from people who died acutely due to a traumatic cause, and these have described in earlier histopathological studies [5, 6] . Samples were obtained from the biobank of VUmc, Amsterdam, The Netherlands. For animal studies, wall thickness measurements in the unilateral lung of rats 6 weeks post-pneumonectomy were compared with those of sham-operated animals.
Evaluation of vasculopathy was performed according to previously described patterns [7] . Immunohistochemical staining with Ki-67, histone H3 and cleaved caspase 3 was performed to determine proliferation and apoptosis of endothelial cells. For quantitative measurements, the thickness of the intimal and medial layers of arterioles (attached to four septal walls) was determined, and expressed as a percentage of the external diameter of these vessels. Vessels with an elliptical shape due to oblique sectioning were excluded.
Animal experiments were permitted by the Institutional Animal Care and Use of the VU University and conducted in accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes, and the Dutch Animal Experimentation Act (FYS12-18, FYS13-01). Sprague-Dawley rats (n=4 per group) underwent either pneumonectomy or sham operation. The animals were part of an earlier study, as described previously [8] .
Lung tissue specimens from 13 patients with MLR and six controls were obtained. Control subjects died at an age of 36±4 years old and were all male. MLR patients were 69±2 years, and 10 out of 13 were male. 10 MLR patients had a known history of smoking and the average survival after surgery was 4.8±0.9 years. The clinical history of four MLR patients was not available. Seven patients had received radiotherapy prior to MLR, three in combination with chemotherapy.
The predominant patterns observed in patients with MLR and absent in controls were thrombotic arteriopathy (46%) and nonselective intimal fibrosis (23%) (figure 1a). These patterns were not associated with the presence of inflammation. In half of the patients with thrombotic arteriopathy, vascular remodelling was mild with slight congestive features. In two patients, diffuse congestion was more prominent, and the last patient showed organising diffuse alveolar damage. All patients with nonspecific intimal fibrosis showed parenchymal intimal fibrosis, with involvement of the veins in two of these patients. Congestive vasculopathy was present both in patients with MLR and controls. In two patients with MLR, this was paired with intimal fibrosis in arterial, parenchymal and venous vessels, medial hyperplasia in bronchiolar arteries, and venous arterialisation. The number of endothelial cells positively staining for the proliferation marker Ki-67 was higher in the MLR group ( p=0.01) (figure 1b), and did not correlate with inflammation ( p=0.50). Histone H3 showed a similar pattern, although this was not statistically significant ( p=0.18). No differences were found for cleaved caspase 3 ( p=0.81) (figure 1b).
In the human pulmonary vasculature, the outer diameter of the arterioles ranged between 27 and 178 μm, with a mean distance of 69 and 76 μm in control and patients with MLR, respectively ( p=0.33). There was no significant increase in the intima thickness in MLR lung tissue, but the media showed a tendency towards thickening (figure 1c). Thickening of the intimal and medial wall was not different in participants with and without inflammation. In rats, the outer diameter was 40±1.3 μm (sham) and 43±2.6 μm (MLR) ( p=0.32). Both vascular layers showed a tendency towards thickening (figure 1d).
The small cohort and random selection of tissue blocks limits the generalisation of our findings. Other limitations are possible confounding factors, including differences in age, smoking history or cancer treatment. Thickening of the intima is often seen in older subjects [9] and smokers [10, 11] . Both features apply to patients undergoing MLR for lung cancer. Chemotherapy and radiotherapy are also associated with vascular, mostly intimal, remodelling [12, 13] . The increased presence of inflammation we found in patients with MLR was probably related to illness at the end of life. However, inflammation was not associated with vasculopathy patterns or proliferation, suggesting that these changes were not consequences of inflammatory activity. We observed increased Ki-67 staining in the MLR group without changes in cleaved caspase 3, indicating ongoing proliferation in the pulmonary vasculature. However, we could not link this observation to a greater intimal thickness.
We hypothesise that pulmonary hyperflow per se could induce remodelling in the pulmonary vasculature, even when no PH develops. Indeed, six of our patients with MLR showed thrombotic arteriopathy, while healthy controls did not present this predominant pattern. Intimal and medial thickness was not changed in human and rat lungs. Finally, patients with MLR showed increased proliferation, without changes in apoptosis. Surprisingly, we observed congestive arteriopathy in half of the control lung samples, indicating that these findings are common and probably nonspecific rather than related to hyperflow.
The findings in our focused study of 13 patients after MLR imply that vascular changes in PH are perhaps partially explained by altered pulmonary blood flow, but further research is needed in a larger cohort with more tissue samples, in order to study which additional stimuli are needed to induce PH.
